Pushpa Patel

Dr. Pushpa Patel

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2009 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
PPPushpa Patel
Pushpa Patel
MVManu Vatish
Manu Vatish
JHJohn Heptinstall
John Heptinstall
RWRui Wang
Rui Wang
RCRay J Carson
Ray J Carson
Background: Hydrogen sulphide is a gas signalling molecule which is produced endogenously from L-cysteine via the enzymes cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE). The possible role of hydrogen sulphide in reproduction has not yet been fully investigated. It has been previously demonstrated that hydrogen sulphide relaxes uterine smooth muscle in vitro. The aim of the present study was to investigate the endogenous production of hydrogen sulphide in rat and human intrauterine tissues in vitro. Methods: The production of hydrogen sulphide in rat and human intrauterine tissues was measured in vitro using a standard technique. The expression of CBS and CSE was also investigated in rat and human intrauterine tissues via Western blotting. Furthermore, the effects of nitric oxide (NO) and low oxygen conditions on the production rates of hydrogen sulphide were investigated. Results: The order of hydrogen sulphide production rates (mean +/- SD, n = 4) for rat tissues were: liver (777 +/- 163 nM/min/g) > uterus (168 +/- 100 nM/min/g) > fetal membranes (22.3 +/- 15.0 nM/min/g) > placenta (11.1 +/- 4.7 nM/min/g), compared to human placenta (200 +/- 102 nM/min/g). NO significantly increased hydrogen sulphide production in rat fetal membranes (P < 0.05). Under low oxygen conditions the production of hydrogen sulphide was significantly elevated in human placenta, rat liver, uterus and fetal membranes (P < 0.05). Western blotting (n = 4) detected the expression of CBS and CSE in all rat intrauterine tissues, and in human placenta, myometrium, amnion and chorion. Conclusion: Rat and human intrauterine tissues produce hydrogen sulphide in vitro possibly via CBS and CSE enzymes. NO increased the production of hydrogen sulphide in rat fetal membranes. The augmentation of hydrogen sulphide production in human intrauterine tissues in a low oxygen environment could have a role in pathophysiology of pregnancy.

17 August 2018 in Blood Advances
Verified
Journal Article
Closed access
PDF file
CSChristopher W. Smith
Christopher W. Smith
ZRZaher Raslan
Zaher Raslan
LPLola Parfitt
Lola Parfitt
AKAbdullah O. Khan
Abdullah O. Khan
PPPushpa Patel
Pushpa Patel
AMAlexandra Mazharian
Alexandra Mazharian
Key Points: Platelet activation in vitro results in a more rapid and greater upregulation of TLT-1 surface expression compared with P-selectin. TLT-1 is more rapidly translocated to the surface of activated platelets than P-selectin during thrombus formation in vivo.

16 July 2021 in Platelets
Verified
Journal Article
Open access
SMSamantha Montague
Samantha Montague
PPPushpa Patel
Pushpa Patel
EMEleyna M. Martin
Eleyna M. Martin
ASAlexandre Slater
Alexandre Slater
LQLourdes Garcia Quintanilla
Lourdes Garcia Quintanilla
SWStephen P. Watson
Stephen P. Watson
Charge interactions play a critical role in the activation of the innate immune system by damage- and pathogen-associated molecular pattern receptors. The ability of these receptors to recognize a wide spectrum of ligands through a common mechanism is critical in host defense. In this article, we argue that platelet glycoprotein receptors that signal through conserved tyrosine-based motifs function as pattern recognition receptors (PRRs) for charged endogenous and exogenous ligands, including sulfated polysaccharides, charged proteins and nanoparticles. This is exemplified by GPVI, CLEC-2 and PEAR1 which are activated by a wide spectrum of endogenous and exogenous ligands, including diesel exhaust particles, sulfated polysaccharides and charged surfaces. We propose that this mechanism has evolved to drive rapid activation of platelets at sites of injury, but that under some conditions it can drive occlusive thrombosis, for example, when blood comes into contact with infectious agents or toxins. In this Opinion Article, we discuss mechanisms behind charge-mediated platelet activation and opportunities for designing nanoparticles and related agents such as dendrimers as novel antithrombotics.

23 August 2024 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
CSChristopher W. Smith
Christopher W. Smith
ZNZoltan Nagy
Zoltan Nagy
MGMitchell J. Geer
Mitchell J. Geer
JPJeremy A. Pike
Jeremy A. Pike
PPPushpa Patel
Pushpa Patel
AMAlexandra Mazharian
Alexandra Mazharian
Inhibition of platelet responsiveness is important for controlling thrombosis. It is well established that platelet endothelial cell adhesion molecule-1 (PECAM-1) serves as a physiological negative regulator of platelet-collagen interactions. We recently demonstrated that leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is a negative regulator of platelet production and reactivity. It is however not known if LAIR-1 and PECAM-1 function in the same or different inhibitory pathways. In this study, we investigated the role of LAIR-1 alongside PECAM-1 in megakaryocyte development and platelet production and determined the functional redundancy through characterization of a LAIR-1/PECAM-1 double knockout (DKO) mouse model. LAIR-1 and PECAM-1 expression in megakaryocytes were evaluated by western blotting. Megakaryocyte ploidy and proplatelet formation were evaluated by flow cytometry and fluorescent microscopy. Platelet function and signalling were compared in wild-type, LAIR-1 -/- , PECAM-1 -/- and DKO mice using aggregometry, flow cytometry and western blotting. Thrombosis was evaluated using the FeCl 3 carotid artery model. We show that LAIR-1/PECAM-1 DKO mice exhibit a 17% increase in platelet count. Bone marrow-derived megakaryocytes from all 3 mouse models had normal ploidy in vitro, suggesting that neither LAIR-1 nor PECAM-1 regulates megakaryocyte development. Furthermore, relative to wild-type platelets, platelets derived from LAIR-1, PECAM-1, and DKO mice were equally hyperresponsive to collagen in vitro, indicating that LAIR-1 and PECAM-1 participate in the same inhibitory pathway. Interestingly, DKO mice exhibited normal thrombus formation in vivo due to DKO mouse platelets lacking the enhanced Src family kinase activation previously shown in platelets from LAIR-1-deficient mice. Findings from this study reveal that LAIR-1 and PECAM-1 act to inhibit GPVI-mediated platelet activation via the same signaling pathway. Mice lacking LAIR-1 and PECAM-1 do not however exhibit an increase in thrombus formation despite minor increase in platelet count and reactivity to collagen. This study adds to the growing evidence that immunoreceptor tyrosine-based inhibition motif-containing receptors are important regulators of platelet count and function.

Verified
Journal Article
Open access
PDF file
Karen AyacheKaren Ayache
Karen Ayache
AVAna Vieira
Ana Vieira
SFSofia Fragoso
Sofia Fragoso
SBSiobhan Brushett
Siobhan Brushett
IGIoannis Konstantinos Gallos
Ioannis Konstantinos Gallos
Christos PapaneophytouChristos Papaneophytou
Christos Papaneophytou
Ovarian cancer (OC) is the most lethal gynecological malignancy, largely because non-specific symptoms contribute to advanced-stage diagnosis and poor prognosis, underscoring the need for improved non-invasive biomarkers. Circulating microRNAs (c-miRNAs) have emerged as promising candidates for OC detection, risk stratification, prognosis, and treatment monitoring. This systematic review, prospectively registered in PROSPERO (CRD420251230898), evaluated the diagnostic and prognostic performance of c-miRNAs and miRNA-based multivariate signatures. MEDLINE/PubMed, Scopus, and CENTRAL were searched from inception to 30 May 2026. Eligible studies assessed c-miRNAs in serum, plasma, whole blood, or extracellular vesicle fractions from women with confirmed or suspected OC including studies using prediagnostic samples from women subsequently diagnosed with OC. Records were screened, data extracted, and risk of bias evaluated according to the type of result using QUADAS-2 for diagnostic accuracy, QUIPS for prognostic-factor associations, and PROBAST for multivariable prediction models. Of 697 records identified, 91 publications met the inclusion criteria. Most studies used case–control or observational designs and analysed serum or plasma samples. Single c-miRNAs generally showed moderate diagnostic accuracy, whereas multivariate miRNA panels and multimodal models incorporating CA-125 or HE4 generally reported higher AUC values, including in some early-stage cohorts. Frequently reported candidates included members of the miR-200 family, miR-21, miR-1246, miR-125b, miR-145, miR-205, and miR-130a. Prognostic studies associated c-miRNAs with survival, recurrence, treatment response, and chemoresistance, although findings were more heterogeneous than diagnostic findings. Risk-of-bias concerns were common, particularly for patient selection in diagnostic studies, confounding in prognostic-factor analyses, and statistical analysis in prediction-model studies. Overall, c-miRNAs represent promising non-invasive biomarkers for OC, particularly when integrated into multivariate or multimodal models. However, methodological heterogeneity, small cohort sizes, limited external validation, and inconsistent reporting currently restrict clinical translation. Future studies should prioritize standardized pre-analytical and analytical workflows, adequately powered prospective cohorts, and independent multicenter validation.

5 September 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Myrtani PieriMyrtani Pieri
Myrtani Pieri
SBSiobhan Brushett
Siobhan Brushett
IGIoannis Konstantinos Gallos
Ioannis Konstantinos Gallos
SFSofia Fragoso
Sofia Fragoso
BSBruno Silva
Bruno Silva
Christos PapaneophytouChristos Papaneophytou
Christos Papaneophytou
Ovarian cancer remains difficult to detect before dissemination, and individual circulating biomarkers are unlikely to capture its biological and clinical heterogeneity. Multimodal liquid biopsy offers a potential route forward, but most biomarker combinations are developed empirically, with limited consideration of the molecular relationships among the measured signals. In this Perspective, we propose that intracellular miRNA dysregulation may provide an organizing layer for integrating glycoprotein/glycan remodeling with blood-derived volatile organic compound (VOC) signatures, while corresponding circulating miRNA profiles constitute a distinct measurable biomarker layer that may only partially reflect the underlying intracellular regulatory state. The miRNA–glycosylation axis is supported by direct mechanistic evidence that selected miRNAs regulate glycogenes and pathways controlling fucosylation, sialylation, and other glycan features. By contrast, the proposed connection between miRNA dysregulation and VOC production is indirect and likely mediated through metabolic reprogramming, mitochondrial dysfunction, oxidative stress, ferroptosis, and lipid peroxidation. We evaluate the evidence supporting each biomarker domain, prioritize candidate bridge miRNAs, including members of the miR-200 family and miR-34a, and define the principal boundary conditions of the framework, including causal inference, disease specificity, histological heterogeneity, VOC source ambiguity, temporal variability, and cross-platform standardization. We further outline a translational strategy based on matched biospecimens, mechanism-aware computational integration, experimental perturbation, longitudinal analysis, and independent validation at clinically relevant specificity thresholds. The objective is not to assert a fixed causal chain, but to provide a testable, clinically oriented framework for moving multimodal ovarian cancer diagnostics from statistical combination to biologically informed integration.